Prevalence and Incidence of Pulmonary fibrosis
Prevalance of types of Pulmonary fibrosis:
For details see prevalence of types of Pulmonary fibrosis analysis; summary of available prevalence data:
Pulmonary fibrosis Prevalence: Book Excerpts
Incidence of types of Pulmonary fibrosis:
For details see incidence of types of Pulmonary fibrosis analysis; summary of available incidence by type data:
Prevalence/Incidence of Pulmonary fibrosis: Online Medical Books
16 MEDICAL BOOKS ONLINE!
Review excerpts from medical books online, free, without registration,
for more information about the prevalence and/or incidence of Pulmonary fibrosis.
Idiopathic pulmonary fibrosis:
Causes and incidence
(Professional Guide to Diseases (Eighth Edition))
IPF is the result of a cascade of events that involve inflammatory, immune, and fibrotic processes in the lung. However, despite many studies and hypotheses, the stimulus that begins the progression remains unknown. Speculation has revolved around viral and genetic causes, but no good evidence has been found to support either theory. However, it’s clear that chronic inflammation plays an important role. Inflammation develops the injury and the fibrosis that ultimately distorts and impairs the structure and function of the alveolocapillary gas exchange surface.
IPF is slightly more common in men than in women and is more common in smokers than in nonsmokers. It usually affects people ages 50 to 70.
» READ BOOK EXCERPT ONLINE »
Source: Professional Guide to Diseases (Eighth Edition), 2005
About prevalence and incidence statistics:
The term 'prevalence' of Pulmonary fibrosis usually refers to the estimated population
of people who are managing Pulmonary fibrosis at any given time.
The term 'incidence' of Pulmonary fibrosis refers to the annual diagnosis rate,
or the number of new cases of Pulmonary fibrosis diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.
Clinical trials are important to the development of new lung cancer treatments. How can they help you?
Doctors are finding that some patients with advanced non-small cell lung cancer may benefit from radiation, chemotherapy and/or newer treatment...
When lung cancer spreads to the bone it can cause severe pain and weak bones. Learn how these bone complications can be treated and even prevented,...
Surgery and radiation are the standard treatments for early-stage lung cancer. Now there's evidence chemotherapy may have a role, too. Listen as...
See full list of 7 related videos
» Next page: Videos related to Pulmonary fibrosis
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: